Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer Quiver Quantitative, Inc. - Mon Dec 9, 5:54PM CST

Achieve Life Sciences announces Mark Oki as Chief Financial Officer to enhance financial strategy and support nicotine dependence treatment development.Quiver AI SummaryAchieve Life Sciences, Inc. has...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer GlobeNewswire - Mon Dec 9, 7:30AM CST

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Announces Successful FDA End-of-Phase 2 Meeting for Cytisinicline as Potential Treatment for Vaping Cessation Quiver Quantitative, Inc. - Tue Dec 3, 5:52PM CST

Achieve Life Sciences reports FDA alignment on Phase 3 trial for cytisinicline, targeting vaping cessation amid public health concerns.Quiver AI SummaryAchieve Life Sciences, Inc. has announced the successful...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA GlobeNewswire - Tue Dec 3, 7:30AM CST

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Participate in Upcoming Investor Conferences in London and New York Quiver Quantitative, Inc. - Thu Nov 14, 5:52PM CST

Achieve Life Sciences announced CEO participation in two investor conferences regarding cytisinicline's development for nicotine dependence treatment.Quiver AI SummaryAchieve Life Sciences, Inc., a late-stage...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences GlobeNewswire - Thu Nov 14, 7:30AM CST

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update GlobeNewswire - Thu Nov 7, 3:05PM CST

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 GlobeNewswire - Thu Oct 24, 7:00AM CDT

ACHV : 3.80 (+0.26%)
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting GlobeNewswire - Wed Oct 23, 7:00AM CDT

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline GlobeNewswire - Wed Oct 16, 7:00AM CDT

ACHV : 3.80 (+0.26%)

Barchart Exclusives

2 Dow Stocks to Buy in 2025 That Also Pay Dividends Barchart - Thu Dec 26, 6:30PM CST
These dividend-paying stocks could be good additions to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot